These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15164803)

  • 1. Seniors with chronic health conditions and prescription drugs: benefits, wealth, and health.
    Saver BG; Doescher MP; Jackson JE; Fishman P
    Value Health; 2004; 7(2):133-43. PubMed ID: 15164803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare beneficiaries' management of capped prescription benefits.
    Cox ER; Jernigan C; Coons SJ; Draugalis JL
    Med Care; 2001 Mar; 39(3):296-301. PubMed ID: 11242323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug coverage, health, and medication acquisition among seniors with one or more chronic conditions.
    Jackson JE; Doescher MP; Saver BG; Fishman P
    Med Care; 2004 Nov; 42(11):1056-65. PubMed ID: 15586832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
    JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?
    Mott DA; Thorpe JM; Thorpe CT; Kreling DH; Gadkari AS
    Res Social Adm Pharm; 2010 Jun; 6(2):90-9. PubMed ID: 20511108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
    Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
    Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage.
    Taira DA; Iwane KA; Chung RS
    Am J Manag Care; 2003 Apr; 9(4):305-12. PubMed ID: 12703674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status.
    Boudreau DM; Doescher MP; Saver BG; Jackson JE; Fishman PA
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):877-84. PubMed ID: 15931653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Rx for reform: a Medicare prescription drug benefit.
    Rak J
    Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
    Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drug spending for Medicare+Choice beneficiaries in the last year of life.
    Fahlman C; Lynn J; Doberman D; Gabel J; Finch M
    J Palliat Med; 2006 Aug; 9(4):884-93. PubMed ID: 16910803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who will be denied Medicare prescription drug subsidies because of the asset test?
    Rice T; Desmond K
    Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Medicare modernization act on low-income persons.
    Havrda DE; Omundsen BA; Bender W; Kirkpatrick MA
    Ann Intern Med; 2005 Oct; 143(8):600-8. PubMed ID: 16230727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population.
    Balkrishnan R; Byerly WG; Camacho FT; Shrestha A; Anderson RT
    Am J Manag Care; 2001 Nov; 7(11):1093-100. PubMed ID: 11725812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.